These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 8513718)

  • 1. Symptomatic treatment of nephrotic syndrome.
    McLigeyo SO
    East Afr Med J; 1993 Jan; 70(1):1-2. PubMed ID: 8513718
    [No Abstract]   [Full Text] [Related]  

  • 2. The nephrotic syndrome.
    Orth SR; Ritz E
    N Engl J Med; 1998 Apr; 338(17):1202-11. PubMed ID: 9554862
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of dietary protein restriction and angiotensin converting enzyme inhibition on protein metabolism in the nephrotic syndrome.
    Don BR; Wada L; Kaysen GA; Schambelan M
    Kidney Int Suppl; 1989 Nov; 27():S163-7. PubMed ID: 2561515
    [No Abstract]   [Full Text] [Related]  

  • 4. Effectiveness of dietary protein augmentation associated with angiotensin-converting enzyme inhibition in the management of the nephrotic syndrome.
    Garini G; Mazzi A; Allegri L; Buzio C; Borghetti A
    Miner Electrolyte Metab; 1996; 22(1-3):123-7. PubMed ID: 8676802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Congenital nephrotic syndrome.
    Jackson LW
    Neonatal Netw; 2007; 26(1):47-55. PubMed ID: 17285887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Congenital nephrotic syndrome responsive to captopril and indometacin.
    Heaton PA; Smales O; Wong W
    Arch Dis Child; 1999 Aug; 81(2):174-5. PubMed ID: 10490532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of steroid resistant nephrotic syndrome.
    ; Gulati A; Bagga A; Gulati S; Mehta KP; Vijayakumar M
    Indian Pediatr; 2009 Jan; 46(1):35-47. PubMed ID: 19179716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Programs of immunosuppressive and anti-inflammatory therapy of primary idiopathic glomerulonephritis. III. Rapidly progressing glomerulonephritis and the use of converting enzyme inhibitors and non-steroidal anti-inflammatory drugs in idiopathic nephrotic syndrome].
    Klinger M; Szewczyk Z
    Przegl Lek; 1989; 46(11):779-83. PubMed ID: 2623185
    [No Abstract]   [Full Text] [Related]  

  • 9. Proteinuria and albumin homeostasis in the nephrotic syndrome: effect of dietary protein intake.
    Rodrigo R; Bravo I; Pino M
    Nutr Rev; 1996 Nov; 54(11 Pt 1):337-47. PubMed ID: 9110562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Interactions of nonsteroid anti-inflammatory drugs with inhibitors of angiotensin-converting enzyme in patients with rheumatic diseases (a review)].
    Tsurko VV; Preobrazhenskiĭ DV; Ob ukhova OA
    Ter Arkh; 2003; 75(5):64-70. PubMed ID: 12847902
    [No Abstract]   [Full Text] [Related]  

  • 11. Nephrotic edema--pathogenesis and treatment.
    Palmer BF
    Am J Med Sci; 1993 Jul; 306(1):53-67. PubMed ID: 8328511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [To what extent can prostaglandin synthesis inhibitors of the non-steroidal antirheumatic (NSAR) type modify the effect of ACE inhibitors?].
    Grote L
    Internist (Berl); 1995 Dec; 36(12):1203-4. PubMed ID: 8567229
    [No Abstract]   [Full Text] [Related]  

  • 13. [Nephrotic syndrome: complications and general principles of treatment].
    Tareeva IE; Poliantseva LR; Kutyrina IM
    Klin Med (Mosk); 1994; 72(2):55-7. PubMed ID: 8015247
    [No Abstract]   [Full Text] [Related]  

  • 14. Adult nephrotic syndrome: non-specific strategies for treatment.
    Charlesworth JA; Gracey DM; Pussell BA
    Nephrology (Carlton); 2008 Feb; 13(1):45-50. PubMed ID: 18199102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Nephrotoxicity of drugs].
    Paoletti V; Mammarella A; Falaschi R; Labbadia G; Donnarumma L; Musca A
    Clin Ter; 1995 Jan; 146(1):49-64. PubMed ID: 7705013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of nephrotic syndrome in adults].
    Honkanen E
    Duodecim; 2000; 116(21):2355-63; quiz 2363-4, 2389. PubMed ID: 12053363
    [No Abstract]   [Full Text] [Related]  

  • 17. Angiotensin converting enzyme inhibitor improves nephrotic syndrome associated with cyanotic congenital heart disease.
    Watanabe Y; Fukuzawa Y; Inaguma D
    Clin Nephrol; 1996 May; 45(5):362-3. PubMed ID: 8738675
    [No Abstract]   [Full Text] [Related]  

  • 18. High potassium. Too much of a good thing.
    Mayo Clin Health Lett; 2009 Feb; 27(2):6. PubMed ID: 19360981
    [No Abstract]   [Full Text] [Related]  

  • 19. Reduction in proteinuria attenuates hyperlipidemia in the nephrotic syndrome.
    Kaysen GA; Davies RW
    J Am Soc Nephrol; 1990 Nov; 1(5 Suppl 2):S75-9. PubMed ID: 16989070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Focus on proteinuria.
    Glassock RJ
    Am J Nephrol; 1990; 10 Suppl 1():88-93. PubMed ID: 2256481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.